Atsushi Kato, PhDa, b, Whitney W. Stevens, MD, PhDa, b, Bruce S. Bochner, MDa
a Department of Medicine, Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
b Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Word Count: 1004 words Conflicts of interest: AK reports a consultant fee from Astellas Pharma and a gift for his research from Lyra Therapeutics. WWS served on advisory boards for GlaxoSmithKline, GenenTech, and Bristol Myers Squibb and on a speaker’s bureau for GlaxoSmithKline. BSB receives publication-related royalty payments from Elsevier and UpToDate. He receives remuneration for consulting services (Glaxo SmithKline, Sanofi/Regeneron) and for serving on the scientific advisory board of Third Harmonic Bio, Inc. and Allakos, Inc. He also own stocks in Allakos. BSB is a co-inventor on existing Siglec-8–related patents and thus may be entitled to a share of royalties received by Johns Hopkins University during development and potential sales of such products. BSB is a co-founder of Allakos, Inc. which makes him subject to certain restrictions under University policy. The terms of this arrangement are being managed by Johns Hopkins University and Northwestern University in accordance with their conflict of interest policies. *Address correspondence to Atsushi Kato, Ph.D., Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, 240 E. Huron, Room M304, Chicago, IL 60611 USA.
Phone: 312-503-0086, FAX: 312-503-0078, E-Mail: a-kato@northwestern.edu